Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 17, 2016

Total Value: $244M (100.0% shares, 0.0% debt)

Holdings (47)

NUVASIVE INC 5.1%
Value $12.45M Shares 230,000 Est. Cost $46.62 Unrealized
AMGN AMGEN INC 5.0%
Value $12.18M Shares 75,000 Est. Cost $116.33 Unrealized +0.1%
WRIGHT MED GROUP N V 5.0%
Value $12.09M Shares 500,000 Est. Cost $24.18 Unrealized
PORTOLA PHARMACEUTICALS INC 4.8%
Value $11.83M Shares 230,000 Est. Cost $48.90 Unrealized
SAGE THERAPEUTICS INC 4.8%
Value $11.66M Shares 200,000 Est. Cost $56.65 Unrealized
SEATTLE GENETICS INC 4.1%
Value $10.1M Shares 225,000 Est. Cost $44.88 Unrealized
MALLINCKRODT PUB LTD CO 4.1%
Value $10.07M Shares 135,000 Est. Cost $65.13 Unrealized
PACB PACIFIC BIOSCIENCES CALIF IN 4.0%
Value $9.848M Shares 750,000 Est. Cost $8.97 Unrealized 0.0%
ACAD ACADIA PHARMACEUTICALS INC 3.6%
Value $8.913M Shares 250,000 Est. Cost $35.23 Unrealized 0.0%
IART INTEGRA LIFESCIENCES HLDGS C 3.3%
Value $8.134M Shares 120,000 Est. Cost $31.26 Unrealized -0.0%
MIRATI THERAPEUTICS INC 3.2%
Value $7.9M Shares 250,000 Est. Cost $31.60 Unrealized
ZELTIQ AESTHETICS INC 3.2%
Value $7.846M Shares 275,000 Est. Cost $27.69 Unrealized
BLUEBIRD BIO INC 3.2%
Value $7.706M Shares 120,000 Est. Cost $64.22 Unrealized
BIIB BIOGEN INC 3.1%
Value $7.659M Shares 25,000 Est. Cost $287.35 Unrealized 0.0%
SPECTRANETICS CORP 2.7%
Value $6.551M Shares 435,000 Est. Cost $13.18 Unrealized
ACHILLION PHARMACEUTICALS IN 2.7%
Value $6.474M Shares 600,000 Est. Cost $8.85 Unrealized
PRTA PROTHENA CORP PLC 2.5%
Value $6.13M Shares 90,000 Est. Cost $60.32 Unrealized 0.0%
NANOSTRING TECHNOLOGIES INC 2.4%
Value $5.884M Shares 400,000 Est. Cost $13.25 Unrealized
NEVRO CORP 2.3%
Value $5.738M Shares 85,000 Est. Cost $67.51 Unrealized
INCY INCYTE CORP 2.2%
Value $5.423M Shares 50,000 Est. Cost $111.83 Unrealized -0.3%
DBV TECHNOLOGIES S A 2.2%
Value $5.314M Shares 80,000 Est. Cost $66.42 Unrealized
VITAE PHARMACEUTICALS INC 2.0%
Value $4.978M Shares 275,000 Est. Cost $12.29 Unrealized
ACORDA THERAPEUTICS INC 1.8%
Value $4.278M Shares 100,000 Est. Cost $26.51 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 1.7%
Value $4.236M Shares 45,000 Est. Cost $92.72 Unrealized 0.0%
FIVE PRIME THERAPEUTICS INC 1.7%
Value $4.15M Shares 100,000 Est. Cost $23.02 Unrealized
TANDEM DIABETES CARE INC 1.7%
Value $4.134M Shares 350,000 Est. Cost $11.81 Unrealized
RETROPHIN INC 1.6%
Value $3.858M Shares 200,000 Est. Cost $19.29 Unrealized
SRPT SAREPTA THERAPEUTICS INC 1.6%
Value $3.858M Shares 100,000 Est. Cost $32.57 Unrealized -0.5%
SYNERGY PHARMACEUTICALS DEL 1.4%
Value $3.402M Shares 600,000 Est. Cost $5.30 Unrealized
GENMARK DIAGNOSTICS INC 1.3%
Value $3.182M Shares 410,000 Est. Cost $9.06 Unrealized
ALCOBRA LTD 1.3%
Value $3.14M Shares 500,000 Est. Cost $5.68 Unrealized
TONIX PHARMACEUTICALS HLDG C 1.1%
Value $2.685M Shares 350,000 Est. Cost $7.16 Unrealized
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 1.0%
Value $2.533M Shares 210,000 Est. Cost $12.06 Unrealized
ENTELLUS MED INC 1.0%
Value $2.529M Shares 150,000 Est. Cost $16.86 Unrealized
VCYT VERACYTE INC 1.0%
Value $2.52M Shares 350,000 Est. Cost $8.42 Unrealized -20.0%
CYNAPSUS THERAPEUTICS INC 0.9%
Value $2.318M Shares 151,630 Est. Cost $16.29 Unrealized
PCRX PACIRA PHARMACEUTICALS INC 0.9%
Value $2.304M Shares 30,000 Est. Cost $61.25 Unrealized -7.6%
CLOVIS ONCOLOGY INC 0.7%
Value $1.75M Shares 50,000 Est. Cost Unrealized
LAB FLUIDIGM CORP DEL 0.7%
Value $1.622M Shares 150,000 Est. Cost $9.82 Unrealized 0.0%
DYNAVAX TECHNOLOGIES CORP 0.5%
Value $1.329M Shares 55,000 Est. Cost $24.16 Unrealized
CORIUM INTL INC 0.4%
Value $1.015M Shares 125,000 Est. Cost $9.35 Unrealized
RGNX REGENXBIO INC 0.4%
Value $996K Shares 60,000 Est. Cost $25.52 Unrealized -22.2%
FOLD AMICUS THERAPEUTICS INC 0.4%
Value $970K Shares 100,000 Est. Cost Unrealized
CPRX CATALYST PHARMACEUTICALS INC 0.4%
Value $921K Shares 376,000 Est. Cost $4.22 Unrealized -32.1%
AKARI THERAPEUTICS PLC 0.3%
Value $683K Shares 47,116 Est. Cost $18.60 Unrealized
STRONGBRIDGE BIOPHARMA PLC 0.2%
Value $553K Shares 72,726 Est. Cost $7.60 Unrealized
OCERA THERAPEUTICS INC 0.2%
Value $390K Shares 125,000 Est. Cost $10.04 Unrealized